Salk Robert, Chang Thomas, D'Costa Walter, Soomekh David, Grogan Kirk
Northern California Foot and Ankle Center, 3838 California Street, Suite No. 108, San Francisco, CA 94118, USA.
Clin Podiatr Med Surg. 2005 Oct;22(4):585-97, vii. doi: 10.1016/j.cpm.2005.07.007.
This pilot study was undertaken to gather preliminary data on the efficacy and safety of viscosupplementation with sodium hyaluronate versus phosphate-buffered saline control for pain associated with osteoarthritis (OA) of the ankle. Results suggest that five weekly intra-articular injections of sodium hyaluronate in patients who have OA of the ankle are well tolerated, can provide sustained relief of pain, and improve ankle function. These findings are consistent with previously published studies using intra-articular injections of sodium hyaluronate in other articular joints but require confirmation in a large, randomized, saline-controlled study. If confirmed, these findings would provide a valuable nonoperative treatment option for patients who have OA of the ankle.
本初步研究旨在收集有关透明质酸钠与磷酸盐缓冲盐水对照进行粘弹性补充治疗踝关节骨关节炎(OA)相关疼痛的疗效和安全性的初步数据。结果表明,对于踝关节骨关节炎患者,每周一次、共五次的关节内注射透明质酸钠耐受性良好,可提供持续的疼痛缓解,并改善踝关节功能。这些发现与先前发表的关于在其他关节内注射透明质酸钠的研究一致,但需要在一项大型、随机、盐水对照研究中得到证实。如果得到证实,这些发现将为踝关节骨关节炎患者提供一种有价值的非手术治疗选择。